Induced pluripotent stem cell-derived vascular smooth muscle cells: Methods and application

Biochemical Journal

Volumn 465, Issue , 2015, Pages 185-194

  Dash, Biraja C ^a   Jiang, Zhengxin ^a   Suh, Carol ^a   Qyang, Yibing ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Induced pluripotent stem cell (iPSC); Regenerative therapy; Signalling; Vascular smooth muscle cell (VSMC)

Indexed keywords

CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL MATURATION; CELL REGENERATION; DISEASE MODEL; EMBRYOID BODY; HUMAN; NONHUMAN; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; REVIEW; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; ANIMAL EMBRYO; METABOLISM; PROCEDURES; VASCULAR DISEASES;

ANIMALS; CELL DIFFERENTIATION; EMBRYO, MAMMALIAN; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MUSCLE, SMOOTH, VASCULAR; REGENERATIVE MEDICINE; VASCULAR DISEASES;

EID: 84920622506     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20141078     Document Type: Review

References (82)

1. Fadini, G. P., Agostini, C. and Avogaro, A. (2010) Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. Atherosclerosis 209, 10-17
2. Griese, D. P., Ehsan, A., Melo, LG., Kong, D., Zhang, L., and Mann., M. J., Pratt, R. E., Mulligan, R. C. and Dzau, V. J. (2003) Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 108, 2710-2715
3. Nakagami, H., Maeda, K., Morishita, R., Iguchi, S., Nishikawa, T., Takami, Y., Kikuchi, Y., Saito, Y., Tamai, K., Ogihara, T. et al. (2005) Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler. Thromb. Vasc. Biol. 25, 2542-2547
4. Li, R. K., and Jia., Z. Q., Weisel, R. D., Merante, F. and Mickle, D. A. (1999) Smooth muscle cell transplantation into myocardial scar tissue improves heart function. J. Mol. Cell Cardiol. 31, 513-522
5. Owens, G. K., Vernon, S. M. and Madsen, C. S. (1996) Molecular regulation of smooth muscle cell differentiation. J. Hypertens. 14, S55-S64
6. Takahashi, K. and Yamanaka, S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676
7. Sinha, S., Iyer, D. and Granata, A. (2014) Embryonic origins of human vascular smooth muscle cells: implications for in vitro modeling and clinical application. Cell. Mol. Life Sci. 71, 2271-2288
8. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. and Yamanaka, S. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872
9. Yu, J., and Vodyanik., M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R. et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920
10. Park, I. H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, TA., Lerou, P. H., Lensch, M. W. and Daley, G. Q. (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141-146
11. Plath, K. and Lowry, W. E. (2011) Progress in understanding reprogramming to the induced pluripotent state. Nat. Rev. Genet. 12, 253-265
12. Woltjen, K., and Michael., I. P., Mohseni, P., Desai, R., Mileikovsky, M., Hamalainen, R., Cowling, R., Wang, W., Liu, P., Gertsenstein, M. et al. (2009) piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458, 766-770
13. Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, II and Thomson, J. A. (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science 324, 797-801
14. Jia, F., and Wilson., K. D., Sun, N., Gupta, D. M., Huang, M., Li, Z., and Panetta., N. J., Chen, Z. Y., Robbins, R. C., Kay, M. A. et al. (2010) A nonviral minicircle vector for deriving human iPS cells. Nat. Methods: 7, 197-199
15. Sommer, C. A., and Sommer., A. G., Longmire, T. A., Christodoulou, C., Thomas, D. D., Gostissa, M., Alt, F. W., Murphy, G. J., Kotton, D. N. et al. (2010) Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector. Stem Cells 28, 64-74
16. Fusaki, N., Ban, H., Nishiyama, A., Saeki, K. and Hasegawa, M. (2009) Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc. Jpn Acad. Ser. B Phys. Biol. Sci. 85, 348-362
17. Seki, T., Yuasa, S., Oda, M., Egashira, T., Yae, K., Kusumoto, D., Nakata, H., Tohyama, S., Hashimoto, H., Kodaira, M. et al. (2010) Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 7, 11-14
18. Ban, H., Nishishita, N., Fusaki, N., Tabata, T., Saeki, K., Shikamura, M., Takada, N., Inoue, M., Hasegawa, M., Kawamata, S. et al. (2011) Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc. Natl. Acad. Sci. U.S.A. 108, 14234-14239
19. Zhou, H., Wu, S., Joo, J. Y., Zhu, S., Han, D. W., Lin, T., Trauger, S., Bien, G., Yao, S., Zhu, Y. et al. (2009) Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4, 381-384
20. Warren, L., and Manos., P. D., Ahfeldt, T., Loh, Y. H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A. et al. (2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618-630
21. Anokye-Danso, F., Trivedi, C. M., Juhr, D., Gupta, M., Cui, Z., Tian, Y., Zhang, Y., Yang, W., Gruber, P. J., Epstein, J. A. and Morrisey, E. E. (2011) Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 8, 376-388
22. Hou, P., Li, Y., Zhang, X., Liu, C., Guan, J., Li, H., Zhao, T., Ye, J., Yang, W., Liu, K. et al. (2013) Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 341, 651-654
23. Shu, J., Wu, C., Wu, Y., Li, Z., Shao, S., Zhao, W., Tang, X., Yang, H., Shen, L., Zuo, X. et al. (2013) Induction of pluripotency in mouse somatic cells with lineage specifiers. Cell 153, 963-975
24. Goh, P. A., Caxaria, S., Casper, C., Rosales, C., and Warner., T. T., Coffey, P. J. and Nathwani, A. C. (2013) A systematic evaluation of integration free reprogramming methods for deriving clinically relevant patient specific induced pluripotent stem (iPS) cells. PloS One 8, e81622
25. Jain, R. K. (2003) Molecular regulation of vessel maturation. Nat. Med. 9, 685-693
26. Spin, J. M., Maegdefessel, L. and Tsao, P. S. (2012) Vascular smooth muscle cell phenotypic plasticity: focus on chromatin remodelling. Cardiovasc. Res. 95, 147-155
27. Majesky, M. W. (2007) Developmental basis of vascular smooth muscle diversity. Arterioscler. Thromb. Vasc. Biol. 27, 1248-1258
28. Villanueva, S., Glavic, A., Ruiz, P. and Mayor, R. (2002) Posteriorization by FGF, Wnt, and retinoic acid is required for neural crest induction. Dev. Biol. 241, 289-301
29. Jiang, X., and Rowitch., D. H., Soriano, P., McMahon, A. P. and Sucov, H. M. (2000) Fate of the mammalian cardiac neural crest. Development 127, 1607-1616
30. Nakamura, T., Colbert, M. C. and Robbins, J. (2006) Neural crest cells retain multipotential characteristics in the developing valves and label the cardiac conduction system. Circ. Res. 98, 1547-1554
31. Wasteson, P., and Johansson., B. R., Jukkola, T., Breuer, S., Akyurek, L. M., Partanen, J. and Lindahl, P. (2008) Developmental origin of smooth muscle cells in the descending aorta in mice. Development 135, 1823-1832
32. Ryckebusch, L., Bertrand, N., Mesbah, K., Bajolle, F., Niederreither, K., Kelly, R. G. and Zaffran, S. (2010) Decreased levels of embryonic retinoic acid synthesis accelerate recovery from arterial growth delay in a mouse model of DiGeorge syndrome. Circ. Res. 106, 686-694
33. High, F. A., Zhang, M., Proweller, A., Tu, L., and Parmacek., M. S., Pear, W. S. and Epstein, J. A. (2007) An essential role for Notch in neural crest during cardiovascular development and smooth muscle differentiation. J. Clin. Invest. 117, 353-363
34. Varadkar, P., Kraman, M., Despres, D., Ma, G., Lozier, J. and McCright, B. (2008) Notch2 is required for the proliferation of cardiac neural crest-derived smooth muscle cells. Dev. Dyn. 237, 1144-1152
35. Mead, T. J. and Yutzey, K. E. (2012) Notch pathway regulation of neural crest cell development in vivo. Dev. Dyn. 241, 376-389
36. Manderfield, L. J., and High., F. A., Engleka, K. A., Liu, F., Li, L., Rentschler, S. and Epstein, J. A. (2012) Notch activation of Jagged1 contributes to the assembly of the arterial wall. Circulation 125, 314-323
37. Buckingham, M., Meilhac, S. and Zaffran, S. (2005) Building the mammalian heart from two sources of myocardial cells. Nat. Rev. Genet. 6, 826-835
38. Kelly, R. G., Brown, N. A. and Buckingham, M. E. (2001) The arterial pole of the mouse heart forms from Fgf10-expressing cells in pharyngeal mesoderm. Dev. Cell 1, 435-440
39. Waldo, K. L., and Hutson., M. R., Ward, C. C., Zdanowicz, M., Stadt, H. A., Kumiski, D., Abu-Issa, R. and Kirby, M. L. (2005) Secondary heart field contributes myocardium and smooth muscle to the arterial pole of the developing heart. Dev. Biol. 281, 78-90
40. Maeda, J., Yamagishi, H., McAnally, J., Yamagishi, C. and Srivastava, D. (2006) Tbx1 is regulated by forkhead proteins in the secondary heart field. Dev. Dyn. 235, 701-710
41. Manner, J., Perez-Pomares, J. M., Macias, D. and Munoz-Chapuli, R. (2001) The origin, formation and developmental significance of the epicardium: a review. Cells Tissues Organs 169, 89-103
42. Landerholm, T. E., and Dong., X. R., Lu, J., Belaguli, N. S., Schwartz, R. J. and Majesky, M. W. (1999) A role for serum response factor in coronary smooth muscle differentiation from proepicardial cells. Development 126, 2053-2062
43. Lu, J., and Landerholm., T. E., Wei, J. S., Dong, X. R., Wu, S. P., Liu, X., Nagata, K., Inagaki, M. and Majesky, M. W. (2001) Coronary smooth muscle differentiation from proepicardial cells requires rhoA-mediated actin reorganization and p160 rho-kinase activity. Dev. Biol. 240, 404-418
44. Mikawa, T. and Gourdie, R. G. (1996) Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with ingrowth of the epicardial organ. Dev. Biol. 174, 221-232
45. Zhou, B., von Gise, A., Ma, Q., Rivera-Feliciano, J. and Pu, W. T. (2008) Nkx2-5- and Isl1-expressing cardiac progenitors contribute to proepicardium. Biochem. Biophys. Res. Commun. 375, 450-453
46. Perez-Pomares, J. M. and de la Pompa, J. L. (2011) Signaling during epicardium and coronary vessel development. Circ. Res. 109, 1429-1442
47. Kruithof, B. P., van Wijk, B., Somi, S., Kruithof-de Julio, M., Perez Pomares, J. M., Weesie, F., Wessels, A., Moorman, A. F. and van den Hoff, M. J. (2006) BMP and FGF regulate the differentiation of multipotential pericardial mesoderm into the myocardial or epicardial lineage. Dev. Biol. 295, 507-522
48. Lavine, K. J., Long, F., Choi, K., Smith, C. and Ornitz, D. M. (2008) Hedgehog signaling to distinct cell types differentially regulates coronary artery and vein development. Development 135, 3161-3171
49. Zamora, M., Manner, J. and Ruiz-Lozano, P. (2007) Epicardium-derived progenitor cells require beta-catenin for coronary artery formation. Proc. Natl. Acad. Sci. U.S.A. 104, 18109-18114
50. Grieskamp, T., Rudat, C., Ludtke, T. H., Norden, J. and Kispert, A. (2011) Notch signaling regulates smooth muscle differentiation of epicardium-derived cells. Circ. Res. 108, 813-823
51. Tang, Y., Urs, S., Boucher, J., Bernaiche, T., Venkatesh, D., Spicer, D. B., Vary, C. P. and Liaw, L. (2010) Notch and transforming growth factor-beta (TGFbeta) signaling pathways cooperatively regulate vascular smooth muscle cell differentiation. J. Biol. Chem. 285, 17556-17563
52. Topouzis, S. and Majesky, M. W. (1996) Smooth muscle lineage diversity in the chick embryo. Dev. Biol. 178, 430-445
53. Owens, 3rd, A. P., Subramanian, V., Moorleghen, J. J., Guo, Z., McNamara, C. A., Cassis, L. A. and Daugherty, A. (2010) Angiotensin II induces a region-specific hyperplasia of the ascending aorta through regulation of inhibitor of differentiation 3. Circ. Res. 106, 611-619
54. Li, J., Zhu, X., Chen, M., Cheng, L., Zhou, D., Lu, M. M., Du, K., Epstein, J. A. and Parmacek, M. S. (2005) Myocardin-related transcription factor B is required in cardiac neural crest for smooth muscle differentiation and cardiovascular development. Proc. Natl. Acad. Sci. U.S.A. 102, 8916-8921
55. Oh, J., Richardson, J. A. and Olson, E. N. (2005) Requirement of myocardin-related transcription factor-B for remodeling of branchial arch arteries and smooth muscle differentiation. Proc. Natl. Acad. Sci. U.S.A. 102, 15122-15127
56. Cheung, C., and Bernardo., A. S., Trotter, M. W., Pedersen, R. A. and Sinha, S. (2012) Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility. Nat. Biotechnol. 30, 165-173
57. Descamps, B. and Emanueli, C. (2012) Vascular differentiation from embryonic stem cells: novel technologies and therapeutic promises. Vasc. Pharmacol. 56, 267-279
58. Ge, X., Ren, Y., Bartulos, O., Lee, M. Y., Yue, Z., Kim, K. Y., Li, W., Amos, P. J., Bozkulak, E. C., Iyer, A. et al. (2012) Modeling supravalvular aortic stenosis syndrome with human induced pluripotent stem cells. Circulation 126, 1695-1704
59. Karamariti, E., Margariti, A., Winkler, B., Wang, X., Hong, X., Baban, D., Ragoussis, J., Huang, Y., Han, J. D., Wong, M. M. et al. (2013) Smooth muscle cells differentiated from reprogrammed embryonic lung fibroblasts through DKK3 signaling are potent for tissue engineering of vascular grafts. Circ. Res. 112, 1433-1443
60. Wanjare, M., Kuo, F. and Gerecht, S. (2013) Derivation and maturation of synthetic and contractile vascular smooth muscle cells from human pluripotent stem cells. Cardiovasc. Res. 97, 321-330
61. Xie, C. Q., Zhang, J., Villacorta, L., Cui, T., Huang, H. and Chen, Y. E. (2007) A highly efficient method to differentiate smooth muscle cells from human embryonic stem cells. Arterioscler. Thromb. Vasc. Biol. 27, e311-e312
62. Lee, T. H., and Song., S. H., Kim, K. L., Yi, J. Y., Shin, G. H., Kim, J. Y., Kim, J., Han, Y. M., Lee, S. H., Lee, S. H. et al. (2010) Functional recapitulation of smooth muscle cells via induced pluripotent stem cells from human aortic smooth muscle cells. Circ. Res. 106, 120-128
63. Lin, B., Kim, J., Li, Y., Pan, H., Carvajal-Vergara, X., Salama, G., Cheng, T., Li, Y., Lo, C. W. and Yang, L. (2012) High-purity enrichment of functional cardiovascular cells from human iPS cells. Cardiovasc. Res. 95, 327-335
64. Menendez, L., and Kulik., M. J., Page, A. T., Park, S. S., Lauderdale, J. D., Cunningham, M. L. and Dalton, S. (2013) Directed differentiation of human pluripotent cells to neural crest stem cells. Nat. Protoc. 8, 203-212
65. Menendez, L., and Yatskievych., T. A., Antin, P. B. and Dalton, S. (2011) Wnt signaling and a Smad pathway blockade direct the differentiation of human pluripotent stem cells to multipotent neural crest cells. Proc. Natl. Acad. Sci. U.S.A. 108, 19240-19245
66. Cao, N., Liang, H., Huang, J., Wang, J., Chen, Y., Chen, Z. and Yang, H. T. (2013) Highly efficient induction and long-term maintenance of multipotent cardiovascular progenitors from human pluripotent stem cells under defined conditions. Cell Res. 23, 1119-1132
67. Bajpai, V. K., Mistriotis, P., Loh, Y. H., Daley, G. Q. and Andreadis, S. T. (2012) Functional vascular smooth muscle cells derived from human induced pluripotent stem cells via mesenchymal stem cell intermediates. Cardiovasc. Res. 96, 391-400
68. Zhang, J., Lian, Q., Zhu, G., Zhou, F., Sui, L., Tan, C., Mutalif, R. A., Navasankari, R., Zhang, Y., Tse, H. F. et al. (2011) A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 8, 31-45
69. Park, S. W., Jun Koh, Y., Jeon, J., Cho, Y. H., Jang, M. J., Kang, Y., Kim, M. J., Choi, C., Sook Cho, Y., Chung, H. M. et al. (2010) Efficient differentiation of human pluripotent stem cells into functional CD34 + progenitor cells by combined modulation of the MEK/ERK and BMP4 signaling pathways. Blood 116, 5762-5772
70. Lee, A. Y., Mahler, N., Best, C., Lee, Y. U. and Breuer, C. K. (2014) Regenerative implants for cardiovascular tissue engineering. J. Lab. Clin. Med. 163, 321-341
71. Stamm, C., Klose, K. and Choi, Y. H. (2010) Clinical application of stem cells in the cardiovascular system. Adv. Biochem. Eng. Biotechnol. 123, 293-317
72. Lu, X. and Zhao, T. (2013) Clinical therapy using iPSCs: hopes and challenges. Genomics Proteomics Bioinformatics 11, 294-298
73. Okano, H., Nakamura, M., Yoshida, K., Okada, Y., Tsuji, O., Nori, S., Ikeda, E., Yamanaka, S. and Miura, K. (2013) Steps toward safe cell therapy using induced pluripotent stem cells. Circ. Res. 112, 523-533
74. Kuroda, T., Yasuda, S. and Sato, Y. (2013) Tumorigenicity studies for human pluripotent stem cell-derived products. Biol. Pharm. Bull. 36, 189-192
75. Hibino, N., and Duncan., D. R., Nalbandian, A., Yi, T., Qyang, Y., Shinoka, T. and Breuer, C. K. (2012) Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts. J. Thorac. Cardiovasc. Surg. 143, 696-703
76. Shin'oka, T., Matsumura, G., Hibino, N., Naito, Y., Watanabe, M., Konuma, T., Sakamoto, T., Nagatsu, M. and Kurosawa, H. (2005) Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. Thorac. Cardiovasc. Surg. 129, 1330-1338
77. McAllister, T. N., Dusserre, N., Maruszewski, M. and L'Heureux, N. (2008) Cell-based therapeutics from an economic perspective: primed for a commercial success or a research sinkhole? Regen. Med. 3, 925-937
78. McAllister, T. N., Maruszewski, M., Garrido, S. A., Wystrychowski, W., Dusserre, N., Marini, A., Zagalski, K., Fiorillo, A., Avila, H., Manglano, X. et al. (2009) Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet 373, 1440-1446
79. Quint, C., Arief, M., Muto, A., Dardik, A. and Niklason, L. E. (2012) Allogeneic human tissue-engineered blood vessel. J Vasc. Surg. 55, 790-798
80. Dahl, S. L., and Kypson., A. P., Lawson, J. H., Blum, J. L., Strader, J. T., Li, Y., Manson, R. J., Tente, W. E., Di Bernardo, L., Hensley, M. T. et al. (2011) Readily available tissue-engineered vascular grafts. Sci. Transl. Med. 3, 68-69
81. Xie, C., Hu, J., Ma, H., Zhang, J., and Chang., L. J., Chen, Y. E. and Ma, P. X. (2011) Three-dimensional growth of iPS cell-derived smooth muscle cells on nanofibrous scaffolds. Biomaterials 32, 4369-4375
82. Lee, M. O., and Moon., S. H., Jeong, H. C., Yi, J. Y., Lee, T. H., Shim, S. H., Rhee, Y. H., Lee, S. H., Oh, S. J., Lee, M. Y. et al. (2013) Inhibition of pluripotent stem cell-derived teratoma formation by small molecules. Proc. Natl. Acad. Sci. U.S.A. 110, E3281-E3290